Loading...
•
Mar 31, 2025
Azenta Q2 2025 Earnings Report
Azenta reported its second quarter results for fiscal year 2025, ended March 31, 2025.
Key Takeaways
Azenta delivered a strong performance in an evolving and uncertain macroeconomic environment, with revenue up 5% year over year and adjusted EBITDA up 75% year over year, demonstrating the resilience of its portfolio.
Revenue from continuing operations increased by 5% year over year to $143 million.
Diluted EPS from continuing operations was ($0.40), while Non-GAAP diluted EPS from continuing operations was $0.05.
Adjusted EBITDA for continuing operations grew by 75% year over year to $14 million, with a margin of 10.0%.
The company ended the quarter with a total balance of cash, cash equivalents, restricted cash, and marketable securities of $540 million.
Revenue by Segment
Forward Guidance
The Company is reiterating its revenue guidance for fiscal year 2025, expecting total organic revenue to grow in the range of 3% to 5% relative to fiscal 2024, and Adjusted EBITDA margin expansion of approximately 300 basis points relative to fiscal 2024.
Positive Outlook
- Total organic revenue is expected to grow in the range of 3% to 5% relative to fiscal 2024.
- Adjusted EBITDA margin expansion is expected to be approximately 300 basis points relative to fiscal 2024.
- The company has a healthy balance sheet and strong cash position.
- Optionality to continue investing in long-term growth plans.
- Continued discipline in capital deployment.
Challenges Ahead
- Uncertainties in global political and economic conditions.
- Possible imposition of additional tariffs on goods imported into the US.
- Volatility of the life sciences markets the Company serves.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...